Table 4. Univariable and Multivariable Logistic Regression Analyses of Factors Significantly associated with the Presence of LGE at Any Location and Specifically in the PM.

		Presence of LGE in PM or LV Myocardium				Presence of LGE in PM
		Univariable		Multivariable		Univariable
		OR (95% CI)	P	OR (95% CI)	P	OR (95% CI)	P
Age		0.99 (0.95–1.03)	0.535			1.02 (0.95–1.09)	0.645
Sex		0.51 (0.19–1.35)	0.174			0.52 (0.11–2.46)	0.406
BSA, m2		2.70 (0.25–29.49)	0.415			2.28 (0.05–98.48)	0.668
Heart failure		1.13 (0.46–4.22)	0.558			1.40 (0.25–7.83)	0.702
Diabetes		0.50 (0.10–2.46)	0.385			0.96 (0.11–8.68)	0.999
Hyperlipidemia		0.00 (0.00–0.00)	1.000			0.00 (0.00–0.00)	1.000
Hypertension		2.22 (0.82–6.03)	0.115			3.17 (0.66–15.24)	0.145
Systolic BP, mm Hg		1.04 (1.01–1.07)	0.005	1.04 (1.01–1.07)	0.013	1.05 (1.01–1.09)	0.027
Diastolic BP, mm Hg		1.05 (1.01–1.09)	0.021			1.05 (0.99–1.11)	0.111
Atrial fibrillation		0.47 (0.18–1.25)	0.129			1.47 (0.27–8.06)	0.657
Ventricular arrhythmia*		2.94 (0.80–10.83)	0.105			6.84 (1.29–36.19)	0.024
Echocardiography
	LVEF, %	1.00 (0.97–1.04)	0.826			1.02 (0.98–1.07)	0.359
	LVEDVI, mL/m2	1.00 (0.99–1.02)	0.602			1.01 (0.98–1.03)	0.664
	LVESVI, mL/m2	1.02 (1.00–1.04)	0.163			1.03 (1.00–1.06)	0.070
	LVMI, g/m2	1.01 (1.00–1.02)	0.466			1.01 (0.99–1.03)	0.404
Presence of MVP		2.91 (1.05–8.08)	0.041	2.38 (0.82–6.91)	0.112	1.44 (0.30–6.83)	0.649
	Anterior leaflet	3.59 (0.93–13.86)	0.064			3.65 (0.61–21.97)	0.157
	Posterior leaflet	1.53 (0.50–4.67)	0.456			0.00 (0.00–0.00)	0.998
	Bi-leaflet	1.19 (0.23–6.17)	0.839			1.52 (0.16–14.28)	0.714

^*Ventricular arrhythmia includes premature ventricular complex, ventricular tachycardia, and ventricular fibrillation. BP = blood pressure, BSA = body surface area, CI = confidence interval, LVEDVI = left ventricular end-diastolic volume index, LVEF = left ventricular ejection fraction, LVESVI = left ventricular end-systolic volume index, LVMI = left ventricular mass index, MVP = mitral valve prolapse, OR = odds ratio, PM = papillary muscle